Financials

News Ideas Discussions Technicals Forecast Seasonals

640 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CHINA RESOURCES PHARMACEUTICAL GROUP LTD operating, investing, and financing activities

640 free cash flow for H2 24 is 2.19 B EUR. For 2024, 640 free cash flow was 1.81 B EUR and operating cash flow was 2.18 B EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—